78 related articles for article (PubMed ID: 8026609)
1. Comparison of two intensified conventional insulin regimens with three and four daily injections.
Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
[TBL] [Abstract][Full Text] [Related]
2. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
Schernthaner G; Kopp HP; Ristic S; Muzyka B; Peter L; Mitteregger G
Horm Metab Res; 2004 Mar; 36(3):188-93. PubMed ID: 15057674
[TBL] [Abstract][Full Text] [Related]
3. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
4. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
[TBL] [Abstract][Full Text] [Related]
5. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
[TBL] [Abstract][Full Text] [Related]
6. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
Scheen AJ; Letiexhe MR; Lefèbvre PJ
Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
[TBL] [Abstract][Full Text] [Related]
7. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
[TBL] [Abstract][Full Text] [Related]
8. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
Moberg EA; Lins PE; Adamson UK
Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
[TBL] [Abstract][Full Text] [Related]
9. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
Roos AN; Meinders AE
Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
[TBL] [Abstract][Full Text] [Related]
10. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
11. [Practical aspects of intensified insulin therapy using the basal bolus principle].
Berger W; Spinas GA
Ther Umsch; 1990 Jan; 47(1):30-40. PubMed ID: 2408180
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal blood glucose profiles in patients with type 1 diabetes mellitus on multiple (> or = 4) daily insulin injection regimens.
Vervoort G; Goldschmidt HM; van Doorn LG
Diabet Med; 1996 Sep; 13(9):794-9. PubMed ID: 8891454
[TBL] [Abstract][Full Text] [Related]
13. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
14. A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients.
Oswald GA; Yudkin JS
Diabetes Res; 1987 Feb; 4(2):85-9. PubMed ID: 3555956
[TBL] [Abstract][Full Text] [Related]
15. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
16. [Intensified insulin therapy in type I diabetes: when and how?].
Martin S
Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):475-80. PubMed ID: 9842692
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
18. [Liberalized diabetic diet for type I diabetics under intensive insulin injection therapy. Follow-up observations for over 2 years].
Chantelau E; Schmolke B; Gösseringer G; Hansen I; Berger M
Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1119-24. PubMed ID: 3891292
[TBL] [Abstract][Full Text] [Related]
19. Clinical observation on brittle diabetes.
Lev-Ran A
Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
[TBL] [Abstract][Full Text] [Related]
20. Controlled study on the use of hand-held insulin dosage computers enabling conversion to and optimizing of meal-related insulin therapy regimens.
Schrezenmeir J; Achterberg H; Bergeler J; Küstner E; Stümer W; Hutten H; Beyer J
Life Support Syst; 1985; 3 Suppl 1():561-7. PubMed ID: 3916620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
